Speaker illustration

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

Member of:

European Society of Cardiology

J. Wouter Jukema, is professor of Cardiology, past Established Clinical Investigator at the Netherlands Heart Foundation and is Chairman of “Leiden Vascular Medicine” at Leiden University Medical Center (LUMC) in the Netherlands. He is also founding director of the Durrer Center for Cardiogenetic Research in Amsterdam. His current interests, which comprise the majority of topics for his more than 1000 peer reviewed publications (with many in top journals like NEJM, Lancet, Science, Nature, Circulation, JACC and EHJ) focus on the field of athero-thrombosis and include interventional cardiology as well as atherosclerosis research (vascular biology, lipid modification, diabetes, anti-thrombotics/anti-platelets and genetics) in humans as well as in transgenic animals. Prof. Jukema is principal investigator in several large interventional/athero-thrombosis studies, a member of various (inter)national athero-thrombosis boards and is holder of multiple (a.o. EU) grants.

Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers

Event: ESC Congress 2022

Topic: Cardiovascular Pharmacotherapy

Session type: Great Debates

Thumbnail

Lipid lowering beyond LDL-cholesterol and statins

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Cardiology Toolbox

Thumbnail

Managing patients with dyslipidaemia: how to tackle clinical inertia

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Drug therapy

Session type: Industry Q&A session

Thumbnail

Coronary artery disease and comorbidities

Event: ESC CONGRESS 2019

Topic: Clinical

Session type: Rapid Fire Abstracts

Thumbnail

Evolving scientific evidence with PCSK9 inhibitors based on ODYSSEY outcomes

Event: ESC CONGRESS 2019

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium

Thumbnail

High sensitivity troponins in patients with suspected acute coronary syndromes

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session type: Advances in Science

Thumbnail

Lipids in atherosclerosis - Evolving concepts

Event: ESC CONGRESS 2017

Topic: Lipids

Session type: Symposium

Thumbnail

Copycat coronary killers

Event: ESC CONGRESS 2016

Topic: Acute intensive cardiovascular care

Session type: Case-Based Symposium

Thumbnail

ACS management 2014: a case based approach according to new guidelines and registries

Event: ESC CONGRESS 2014

Topic: Thrombosis and platelets

Session type: EBAC Accredited Educational Programme

Thumbnail

Targeting dyslipidaemia and cardiovascular disease prevention: a life-long campaign

Event: ESC Congress 2013

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: EBAC Accredited Educational Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk